Literature DB >> 27826887

Diagnosis of Invasive Pulmonary Aspergillosis.

E Swoboda-Kopeć1, M Sikora2, K Piskorska3, M Gołaś1, I Netsvyetayeva1, D Przybyłowska4, E Mierzwińska-Nastalska4.   

Abstract

Culturing strains from clinical samples is the main method to diagnose invasive pulmonary aspergillosis. Detecting the galactomannan antigen in serum samples is an auxiliary examination. The goal of this study was to determine the frequency with which Aspergillus fumigatus was cultured in clinical samples taken from patients hospitalized in the the Infant Jesus Teaching Hospital in Warsaw, Poland, in the period of 2013-2014. Specimens from the respiratory tract and blood were cultured for mycological and serological assessments. Strain isolation was performed in chloramphenicol Sabouraud agar. Species identification was based on morphological traits in macro-cultures and on microscopic examination. The galactomannan antigen was detected by ELISA method. Out of 2000 clinical samples with positive mycological results, 200 were obtained from the respiratory tract. A. fumigatus was cultured in 13 cases from the respiratory group. Ten cases were cultured out of tracheal aspirates and three from bronchoalveolar lavage fluid. The galactomannan antigen was detected in a serum sample from only one out of the 13 patients with cultures positive for A. fumigatus. It also was detected in serum samples of three other patients in whom A. fumigatus culture yielded a negative result. We conclude that culture-confirmed invasive pulmonary aspergillosis represents a scarce finding. A. fumigatus cultured from clinical samples may not always be confirmed by ELISA assay and vice versa a positive ELISA result does not attest the successful culture.

Entities:  

Keywords:  Aspergillosis; Aspergillus fumigates; Diagnostics; ELISA; Galactomannan antigen; Lungs; Respiratory tract

Mesh:

Substances:

Year:  2017        PMID: 27826887     DOI: 10.1007/5584_2016_46

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

Review 1.  Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.

Authors:  Matthew W McCarthy; Ruta Petraitiene; Thomas J Walsh
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

2.  Special Staining of the Liquid-Based Cytopathology Test in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients.

Authors:  Yue Hu; Lin Zheng; Deng Pan; Lei Shao; Xianfa Xu; Yiming Yu; Qidong Zhuang; Zaichun Deng; Zhongbo Chen
Journal:  Can Respir J       Date:  2020-03-31       Impact factor: 2.409

3.  Comparing the diagnostic value of bronchoalveolar lavage fluid galactomannan, serum galactomannanan, and serum 1,3-β-d-glucan in non-neutropenic respiratory disease patients with invasive pulmonary aspergillosis.

Authors:  Zhang Dai; Minjing Cai; Yihui Yao; Jianhui Zhu; Lingqing Lin; Lili Fang; Zhimeng Li; Huochun Yi; Bo Chen; Xianming Liang
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

4.  Potential value of serum Aspergillus IgG antibody detection in the diagnosis of invasive and chronic pulmonary aspergillosis in non-agranulocytic patients.

Authors:  Qihong Yu; Jingdong He; Bin Xing; Xin Li; Hongyu Qian; Hong Zhang; Meilin Xu; Haiying Peng
Journal:  BMC Pulm Med       Date:  2020-04-15       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.